ILMN

MKT CAP:$25B

Illumina Inc

Market Cap

$25B

Healthcare·Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Diagnostics·🇺🇸·NASDAQ

Stock Price

$158.04+$23.69 (+17.63%)

Jun 8, 2026

52W High $170.9352W Low $84.98

Company Details

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments...

CEO

—

IPO Date

Jul 28, 2000

Website

www.illumina.com

Key Metrics TTM

Revenue

$4.4B

+1.2% YoY

Net Income

$853M

EPS (Diluted)

Free Cash Flow

$989M

Revenue / Share

$28.51

Gross Margin

67.7%

Operating Margin

21.5%

Net Margin

19.4%

FCF Margin

22.5%

P/S

5.7x

P/E

29.2x

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

May 4, 2026

$1.1B+4.8%

FY 2025

Feb 12, 2026

$4.3B-0.8%

Q4 2025

Feb 12, 2026

$1.2B+5.1%

Q3 2025

Oct 31, 2025

$1.1B+0.3%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee